ArticleCell death discovery2025
SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance.
Guojiang Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it